News
4d
MedPage Today on MSNACIP Endorses RSV Vaccine for At-Risk Adults 50 and UpThe CDC's Advisory Committee on Immunization Practices (ACIP) voted 14-0, with one abstention, on Wednesday to recommend that ...
Vote expands existing recommendation, which was for all adults aged 75 and older and high-risk adults aged 60 to 74 Pfizer Inc. (NYSE: PFE) announced today that the U.S. Centers for Disease ...
The new recommendations include: Adults aged 50 to 59 with certain health problems, like heart disease, diabetes or chronic obstructive pulmonary disorder should be able to get the RSV shot.
Researchers found that 47.2% of the 3219 unvaccinated adults had not heard of RSV vaccine or were unsure. HealthDay News — Knowledge of respiratory syncytial virus (RSV) disease and RSV ...
A three-year study has found robust evidence that one particular vaccine for respiratory syncytial virus (RSV) offers older adults long-term protection against the infection, even if efficacy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results